The race to obtain regulator approval for the launch of the vaccine has entered its final stretch in India and the government is beefing up plans to immunize 30 million high-risk people in phase 1. Amid these developments, India and South Africa, backed by other low-income and developing countries, are …
Read More »India and South Africa seek to free Covid-19 drugs and vaccines from patents and intellectual property rights. This is why
